The Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) was established under Regulation 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices.

The MSSG will be ensuring a robust response to issues impacting the quality, safety, efficacy and supply of medicinal products during major events or public health emergencies.